- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Alkermes Launches New Website Offering Education About Alcohol Dependence
Dublin-headquarted biopharma Alkermes has launched a new website to offer education about alcohol dependence. Myrelationshipwithalcohol.com offers educational information about alcohol dependence, an interactive questionnaire developed by the National Institutes of Health (NIH) designed to assess personal drinking patterns, and a discussion guide to help start a conversation with healthcare providers about the disease and treatment options.
"As one of the few companies working in this disease area, we felt compelled to develop a resource to help people better understand alcohol dependence," commented Blair Jackson, Executive Vice President, Chief Operating Officer of Alkermes. ”Despite its prevalence, understanding of the disease itself and awareness of approved treatment options that exist remain low. Our aim is to provide people who may be living with the disease, or those who are caring for people living with it, with information to help empower them to speak with a healthcare provider.”
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
